Monday, March 23

How Recent Shifts Are Rewriting the Story for Science Applications International Stock


Science Applications International is back in focus after a modest trim to its fair value estimate to about $113.38 from $116.00, as analysts recalibrate their models in light of a more cautious revenue outlook. The shift reflects a slightly higher discount rate, near 8.30% versus roughly 7.95%, alongside a somewhat brighter long term revenue growth assumption of about 1.44% compared with 1.04%. This captures both funding uncertainty and potential for gradual top line improvement. Read on to see how you can stay ahead of these evolving assumptions and keep track of the shifting narrative around SAIC.

Stay updated as the Fair Value for Science Applications International shifts by adding it to your watchlist or portfolio. Alternatively, explore our Community to discover new perspectives on Science Applications International.

🐂 Bullish Takeaways

  • Stifel remains constructive on SAIC even after trimming its target to $128 from $130, keeping a Buy rating and arguing the stock still screens as an attractive value idea despite a weaker revenue outlook.

  • Supportive analysts highlight that, while near term market challenges are persisting, management is taking actions to navigate the environment, which they see as creating a potential opportunity if execution stabilizes revenue trends.

  • More optimistic commentary focuses on SAIC’s ability to preserve margins and cash generation in a tough backdrop, which underpins the view that much of the bad news may already be reflected in the current valuation.

🐻 Bearish Takeaways

  • Goldman Sachs turned more negative, cutting its price target to $91 from $104 with a Sell rating, citing organic revenue decline in Q2, reduced FY26 guidance, and the risk of a multi year slowdown in revenue and margins as government priorities and funding are reallocated.

  • JPMorgan downgraded SAIC to Neutral from Overweight and lowered its target to $115 from $140, pointing to a meaningfully reduced sales outlook, sluggish revenue expected in coming quarters, and continued difficulty generating on contract growth.

  • Jefferies, which maintains a Hold rating while cutting its target to $115 from $130, now models a 2% revenue contraction in FY26, underscoring how tightening scrutiny on scope additions is weighing on growth and feeding a more cautious stance on valuation and execution risk.

Do your thoughts align with the Bull or Bear Analysts? Perhaps you think there’s more to the story. Head to the Simply Wall St Community to discover more perspectives or begin writing your own Narrative!



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *